Top Line

The US government has signed an agreement to buy 10 million courses of Pfizer’s antiviral COVID-19 pill, the company announced Thursday, the latest in a string of purchases, as officials secure a limited supply of new coronavirus treatments.

important facts

- Advertisement -

US will spend about $5.3 billion on Pfizer’s drug Paxlovid said, conditional upon being approved for use by the Food and Drug Administration (FDA).

Pfizer said it will begin delivering courses later this year and will complete orders in 2022.

The deal adds to a growing US stockpile of new treatments that experts think may mark a turn in the pandemic.

The US signed two deals with Merck and Ridgeback Biotherapeutics to buy 3.1 million courses of mollupiravir, another antiviral pill, which regulators Be expected To review at the end of November.

the government also Agreed To purchase 700,000 doses of AstraZeneca’s injectable antibody cocktail, which trials indicate may reduce the risk of death or severe COVID-19 and also protect against symptomatic infection.

- Advertisement -